Sonnipe Ltd’s Boston Scientific BSX Stock Holding History

Sonnipe Ltd’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-15,208	Closed	-$1.04M	–	7
2024 Q1	$1.04M	Hold	15,208	–	–	0.11%	7
2023 Q4	$879K	Sell	15,208 -3,996	-21%	-$213K	0.11%	11
2023 Q3	$1.01M	Sell	19,204 -882	-4%	-$46.3K	0.15%	8
2023 Q2	$1.09M	Hold	20,086	–	–	0.15%	9
2023 Q1	$1M	Buy	20,086 +1,995	+11%	+$94K	0.16%	9
2022 Q4	$837K	Buy	+18,091	New	+$783K	0.16%	8

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sonnipe Ltd's BSX Position: Q2 2024 in Review

Sonnipe Ltd sold out of Boston Scientific (BSX) in Q2 2024, closing a stake of 15,208 shares — an estimated $1.04M sold.

Sonnipe Ltd first reported a position in BSX in Q4 2022 and held it in 6 quarters. The position peaked at $1.09M in Q2 2023. 1,321 funds tracked by Wall St. Rank hold BSX as of Q2 2024.

Sonnipe Ltd reported no remaining Boston Scientific position as of Q2 2024 after selling out during the quarter.
Sonnipe Ltd sold 15,208 Boston Scientific shares in Q2 2024, an estimated $1.04M.
Sonnipe Ltd first reported a position in Boston Scientific in Q4 2022 and held it in 6 quarters.
Sonnipe Ltd's Boston Scientific position peaked at $1.09M in Q2 2023.
1,321 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2024.

Based on Sonnipe Ltd's 13F filing for Q2 2024, filed 9 Aug 2024.